Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the effect of Beraksurf and Cursorf in patients with respiratory distress
IRCT20120126008827N3Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of beractant in respiratory distress syndrome (RDS), sponsored by Shiraz University of Medical Sciences. Started Dec 2021; status: completed.
02
Drugs
beractant
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT20120126008827N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120126008827N3.